ARS Pharmaceuticals, Inc
Biotechnology
Healthcare
SPRY
98.06 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.91
52 week high
18.35
high
10.12
52 week low
0.00
low
9.81
growth
-32.70 %
previous Close
9.79
P/E ratio
market cap
1.62 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
425.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top